Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.

Maria FiliEric TrocmeChristina HerrspiegelStefan SeregardGustav Stålhammar

Published in: The British journal of ophthalmology (2020)

There are no increased hazards for choroidal melanoma-related mortality after brachytherapy with decreasing doses between 108.6 and 73.0 Gy, or with decreasing dose rates between 2.8 and 0.5 Gy/hour.

Keyphrases

high dose
optical coherence tomography
radiation therapy
blood pressure
skin cancer
type diabetes
low dose
squamous cell carcinoma
cardiovascular disease
optic nerve